Related references
Note: Only part of the references are listed.Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta-Analysis of Randomized Clinical Trials
Navid Naghsh et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2023)
Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Sophia T. Tan et al.
NATURE MEDICINE (2023)
Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials
Mohammad Jafar Dehzad et al.
CYTOKINE (2023)
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh et al.
NATURE IMMUNOLOGY (2022)
Pathological sequelae of long-haul COVID
Saurabh Mehandru et al.
NATURE IMMUNOLOGY (2022)
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
Heba N. Altarawneh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021
Amelia G. Johnson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies
Atala B. Jena et al.
SCIENTIFIC REPORTS (2021)
Attributes and predictors of long COVID
Carole H. Sudre et al.
NATURE MEDICINE (2021)
Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications
Nan Xiao et al.
NATURE COMMUNICATIONS (2021)
Years of life lost to COVID-19 in 81 countries
Hector Pifarre i Arolas et al.
SCIENTIFIC REPORTS (2021)
Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures
Ying Peng et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Nutrition and immunity: lessons for COVID-19
Philip C. Calder
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
M. G. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
INTERNATIONAL IMMUNOLOGY (2021)
Antiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19
Rajesh K. Thimmulappa et al.
HELIYON (2021)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
Marthe Jontvedt Jorgensen et al.
SCIENTIFIC REPORTS (2020)
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
Sara E. Oliver et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®)
D. Briskey et al.
EUROPEAN JOURNAL OF NUTRITION (2019)
Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-κB signaling pathway
Indrajit Chowdhury et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia
Boya Zhang et al.
FASEB JOURNAL (2019)
Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials
C. Michael White et al.
PHARMACOLOGICAL RESEARCH (2019)
Curcumin Attenuates Airway Inflammation and Airway Remolding by Inhibiting NF-B Signaling and COX-2 in Cigarette Smoke-Induced COPD Mice
Jin Yuan et al.
INFLAMMATION (2018)
Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-kappa B pathways
Jianping Dai et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome
Haipeng Yin et al.
JOURNAL OF IMMUNOLOGY (2018)
Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives
Xiao-Yu Xu et al.
NUTRIENTS (2018)
The emerging role of curcumin for improving vascular dysfunction: A review
Marilyn S. Campbell et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production
Shuguang Han et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Ajaikumar B. Kunnumakkara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding
Bryan C. Mounce et al.
ANTIVIRAL RESEARCH (2017)
Oral bioavailability of curcumin: problems and advancements
Weidong Liu et al.
JOURNAL OF DRUG TARGETING (2016)
Effect of curcumin on circulating interleukin-6 concentrations: A systematic review and meta-analysis of randomized controlled trials
Giuseppe Derosa et al.
PHARMACOLOGICAL RESEARCH (2016)
Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity
Janette Bester et al.
SCIENTIFIC REPORTS (2016)
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
Anggakusuma et al.
GUT (2014)
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
Sahdeo Prasad et al.
CANCER RESEARCH AND TREATMENT (2014)
Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome
Sreedevi Avasarala et al.
PLOS ONE (2013)
Endogenous PGE2 induces MCP-1 expression via EP4/p38 MAPK signaling in melanoma
Mingrui Tang et al.
ONCOLOGY LETTERS (2013)
Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells
Yi Zhong et al.
INFLAMMATION RESEARCH (2012)
Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition
Se-Woong Oh et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
Innate and adaptive immunosenescence
Shradha Agarwal et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways
Amy Wing Yin Ho et al.
IMMUNOBIOLOGY (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Chemokines and chemokine receptors in leukocyte trafficking
TS Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)